Pacira BioSciences (PCRX) Current Assets (2010 - 2026)

Pacira BioSciences' Current Assets history runs 17 years deep, the most recent figure standing at $515.0 million for Q1 2026.

• In Q1 2026, Current Assets fell 32.24% year-over-year to $515.0 million; the TTM figure through Mar 2026 stood at $515.0 million (down 32.24% YoY), while the FY2025 annual figure was $548.0 million, down 26.46% from the prior year.
• Current Assets was $515.0 million for Q1 2026 at Pacira BioSciences, down from $548.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $760.0 million in Q1 2025 to a low of $376.1 million in Q1 2023.
• Historically, Current Assets has averaged $572.3 million across 5 years, with a median of $543.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Assets slumped 43.61% in 2023, then jumped 54.27% in 2024.
• A 5-year view of Current Assets shows it stood at $498.3 million in 2022, then climbed by 2.34% to $510.0 million in 2023, then soared by 46.11% to $745.1 million in 2024, then retreated by 26.46% to $548.0 million in 2025, then decreased by 6.02% to $515.0 million in 2026.
• The last three Current Assets figures came in at $515.0 million (Q1 2026), $548.0 million (Q4 2025), and $562.8 million (Q3 2025), per Business Quant data.